{"id":"W4403812934","doi":"10.1093/eurheartj/ehae666.3038","title":"Treatment of Post-COVID-19 POTS by inhibiting FcRn: a phase 2 randomized, placebo controlled, double-blind, proof of concept study with efgartigimod","year":2024,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Placebo; Double blind; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Randomized controlled trial; Proof of concept; Internal medicine; Virology; Pharmacology; Pathology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002372758,0.0003172987,0.001587564,0.000334981,0.0001889974,0.00009169962,0.0001101061,0.00002693566,0.0001874198],"category_scores_gemma":[0.000572443,0.0001804343,0.000412151,0.0003090358,0.0004013787,0.0001354195,0.000061817,0.0003987779,0.00001100481],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003290625,"about_ca_system_score_gemma":0.0009233567,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007509976,"about_ca_topic_score_gemma":0.000009503214,"domain_scores_codex":[0.9961107,0.001188558,0.0009634193,0.0003646364,0.0009416725,0.000430953],"domain_scores_gemma":[0.9977443,0.0007941831,0.0003060772,0.0002447157,0.0004069148,0.0005038338],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9658344,0.00276563,0.001203903,0.0003252589,0.0036771,0.002717461,0.01172849,0.00009306754,0.004084908,0.00001703962,0.004693921,0.002858764],"study_design_scores_gemma":[0.9586175,0.01981408,0.00002539039,0.0005993423,0.001017742,0.001534744,0.00321214,0.0001978205,0.01053142,0.000004144218,0.004273333,0.000172341],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9674345,0.01512219,0.0005508346,0.005617866,0.0001574036,0.007264264,0.00005560634,0.00007202545,0.003725316],"genre_scores_gemma":[0.9976079,0.0001490391,0.0001474626,0.0001663102,0.0004259681,0.0001134727,0.00001030889,0.00006949558,0.001310037],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03017342,"threshold_uncertainty_score":0.7357897,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06484357411088452,"score_gpt":0.4080139338656373,"score_spread":0.3431703597547528,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}